1. Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.
- Author
-
Quaegebeur A, Segura I, Schmieder R, Verdegem D, Decimo I, Bifari F, Dresselaers T, Eelen G, Ghosh D, Davidson SM, Schoors S, Broekaert D, Cruys B, Govaerts K, De Legher C, Bouché A, Schoonjans L, Ramer MS, Hung G, Bossaert G, Cleveland DW, Himmelreich U, Voets T, Lemmens R, Bennett CF, Robberecht W, De Bock K, Dewerchin M, Ghesquière B, Fendt SM, and Carmeliet P
- Subjects
- Animals, Brain blood supply, Brain drug effects, Brain pathology, Brain Ischemia complications, Carbon metabolism, Free Radical Scavengers metabolism, Hydroxylation, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Injections, Intraventricular, Mice, Knockout, Neurons drug effects, Neuroprotection drug effects, Oligonucleotides administration & dosage, Oligonucleotides pharmacology, Oxidation-Reduction drug effects, Pentose Phosphate Pathway drug effects, Phenotype, Procollagen-Proline Dioxygenase deficiency, Reactive Oxygen Species metabolism, Stroke complications, Brain Ischemia prevention & control, Cellular Reprogramming drug effects, Gene Deletion, Neurons metabolism, Oxygen metabolism, Procollagen-Proline Dioxygenase metabolism, Stroke prevention & control
- Abstract
The oxygen-sensing prolyl hydroxylase domain proteins (PHDs) regulate cellular metabolism, but their role in neuronal metabolism during stroke is unknown. Here we report that PHD1 deficiency provides neuroprotection in a murine model of permanent brain ischemia. This was not due to an increased collateral vessel network. Instead, PHD1(-/-) neurons were protected against oxygen-nutrient deprivation by reprogramming glucose metabolism. Indeed, PHD1(-/-) neurons enhanced glucose flux through the oxidative pentose phosphate pathway by diverting glucose away from glycolysis. As a result, PHD1(-/-) neurons increased their redox buffering capacity to scavenge oxygen radicals in ischemia. Intracerebroventricular injection of PHD1-antisense oligonucleotides reduced the cerebral infarct size and neurological deficits following stroke. These data identify PHD1 as a regulator of neuronal metabolism and a potential therapeutic target in ischemic stroke., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF